Pathological response and tumor-infiltrating-lymphocytes post neoadjuvant chemotherapy.

被引:0
|
作者
Roque, Katia Mercedes
Nino, Marco Galvez
Castaneda Altamirano, Carlos Arturo
Garcia, Miluska Castillo
Sanchez, Joselyn
Bernabe, Luis A.
Fuentes, Hugo Alejandro
Sandival, Gustavo
Cotrina, Jose M.
Dunstan, Jorge Antonio
Abugattas, Julio
Mantilla, Raul
De La Cruz, Miguel
Gomez, Henry Leonidas
机构
[1] Inst Nacl Enfermedades Neoplas, Lima, Peru
[2] Oncosalud Auna, Lima, Peru
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e12654
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Tumor Infiltrating Lymphocytes and Response To Neoadjuvant Chemotherapy in Invasive Breast Cancer
    Fineberg, Susan
    McLemore, Lauren
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 45A - 45A
  • [2] Tumor Infiltrating Lymphocytes and Response To Neoadjuvant Chemotherapy in Invasive Breast Cancer
    Fineberg, Susan
    McLemore, Lauren
    [J]. MODERN PATHOLOGY, 2015, 28 : 45A - 45A
  • [3] Predictive and prognostic value of tumor-infiltrating lymphocytes in breast cancer treated with neoadjuvant chemotherapy.
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Hiraiwa, Kunihiko
    Nakamura, Tetsuya
    Saito, Junichi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [4] Ultrasound features combined with tumor-infiltrating lymphocytes for prediction of pathological response to neoadjuvant chemotherapy in breast cancer
    Jia, Yingying
    Zhou, Xin
    Zhu, Yangyang
    Song, Xuewen
    Duan, Ying
    Chen, Kundi
    Nie, Fang
    [J]. MEDICAL ULTRASONOGRAPHY, 2023, 25 (02) : 131 - 138
  • [5] Stromal tumor infiltrating lymphocytes and pathological complete response in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy
    De Schepper, Maxim
    Nguyen, Ha-Linh
    Richard, Francois
    Lerebours, Florence
    Vion, Roman
    Clatot, Florian
    Berghian, Anca
    Maetens, Marion
    Leduc, Sophia
    Isnaldi, Edoardo
    Molinelli, Chiara
    Lambertini, Matteo
    Grillo, Frederica
    Zoppoli, Gabriele
    Dirix, Luc
    Wuyts, Hilde
    Punie, Kevin
    Wildiers, Hans
    Remmerie, Chantal
    Smeets, Ann
    Nevelsteen, Ines
    Neven, Patrick
    Salomon, Anne
    Larsimont, Denis
    Duhem, Caroline
    Viens, Patrice
    Bertucci, Francois
    Biganzoli, Elia
    Vermeulen, Peter
    Floris, Giuseppe
    Desmedt, Christine
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [6] Tumor-infiltrating lymphocytes are an important pathological predictor for neoadjuvant chemotherapy in patients with breast cancer
    Yamaguchi, R.
    Tanaka, M.
    Yano, A.
    Yamaguchi, M.
    Yano, H.
    [J]. BREAST, 2011, 20 : S76 - S76
  • [7] Tumor Infiltrating Lymphocytes (TILs) in triple-negative breast cancer: High Immunoscore is associated with pathological CR in patients receiving neoadjuvant chemotherapy.
    Rapoport, Bernardo
    Nayler, Simon
    Galon, Jerome
    Mlecnik, T.
    Smit, Teresa
    Barnard-Tidy, Jacqui
    Fugon, Aurelie
    Martel, Marine
    Anderson, Ronald
    Benn, Carol
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [8] Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma
    Hornychova, Helena
    Melichar, Bohuslav
    Tomsova, Marketa
    Mergancova, Jindiska
    Urminska, Hana
    Ryska, Ales
    [J]. CANCER INVESTIGATION, 2008, 26 (10) : 1024 - 1031
  • [9] Association of tumor-infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
    Hong, Jin
    Rui, Weiwei
    Fei, Xiaochun
    Chen, Xiaosong
    Shen, Kunwei
    [J]. CANCER MEDICINE, 2021, 10 (22): : 7921 - 7933
  • [10] Predictive value of tumor-infiltrating lymphocytes for pathological response to neoadjuvant chemotherapy in breast cancer patients with axillary lymph node metastasis
    Yokotani, Tomoyo
    Ikeda, Noaya
    Hirao, Tomoko
    Tanaka, Yukimi
    Morita, Kohei
    Fujii, Tomomi
    Ohbayashi, Chiho
    Nakamura, Takashi
    Kobayashi, Toyoki
    Sho, Masayuki
    [J]. SURGERY TODAY, 2021, 51 (04) : 595 - 604